Literature DB >> 34800629

O-GlcNAcylation regulation of cellular signaling in cancer.

Lorela Ciraku1, Emily M Esquea1, Mauricio J Reginato2.   

Abstract

O-GlcNAcylation is a post-translational modification occurring on serine/threonine residues of nuclear and cytoplasmic proteins, mediated by the enzymes OGT and OGA which catalyze the addition or removal of the UDP-GlcNAc moieties, respectively. Structural changes brought by this modification lead to alternations of protein stability, protein-protein interactions, and phosphorylation. Importantly, O-GlcNAcylation is a nutrient sensor by coupling nutrient sensing with cellular signaling. Elevated levels of OGT and O-GlcNAc have been reported in a variety of cancers and has been linked to regulation of multiple cancer signaling pathways. In this review, we discuss the most recent findings on the role of O-GlcNAcylation as a metabolic sensor in signaling pathways and immune response in cancer.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Metabolism; O-GlcNAc; OGT; Signaling; Transcription; cancer

Mesh:

Substances:

Year:  2021        PMID: 34800629      PMCID: PMC8712408          DOI: 10.1016/j.cellsig.2021.110201

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  166 in total

1.  YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response.

Authors:  Luca Azzolin; Tito Panciera; Sandra Soligo; Elena Enzo; Silvio Bicciato; Sirio Dupont; Silvia Bresolin; Chiara Frasson; Giuseppe Basso; Vincenza Guzzardo; Ambrogio Fassina; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cell       Date:  2014-06-26       Impact factor: 41.582

Review 2.  Role of MTA1 in cancer progression and metastasis.

Authors:  Nirmalya Sen; Bin Gui; Rakesh Kumar
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

3.  O-GlcNAc modification regulates MTA1 transcriptional activity during breast cancer cell genotoxic adaptation.

Authors:  Xueqin Xie; Qiutong Wu; Keren Zhang; Yimin Liu; Nana Zhang; Qiushi Chen; Lingyan Wang; Wenli Li; Jianing Zhang; Yubo Liu
Journal:  Biochim Biophys Acta Gen Subj       Date:  2021-05-18       Impact factor: 3.770

4.  Posttranscriptional regulation of de novo lipogenesis by glucose-induced O-GlcNAcylation.

Authors:  Wei Tan; Pei Jiang; Wanjun Zhang; Zhaohua Hu; Shaofeng Lin; Lulu Chen; Yingge Li; Changmin Peng; Zhuqing Li; Aihua Sun; Yali Chen; Wenge Zhu; Yu Xue; Yi Yao; Xiangpan Li; Qibin Song; Fuchu He; Weijie Qin; Huadong Pei
Journal:  Mol Cell       Date:  2021-03-02       Impact factor: 17.970

5.  Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9.

Authors:  Harri M Itkonen; Ninu Poulose; Rebecca E Steele; Sara E S Martin; Zebulon G Levine; Damien Y Duveau; Ryan Carelli; Reema Singh; Alfonso Urbanucci; Massimo Loda; Craig J Thomas; Ian G Mills; Suzanne Walker
Journal:  Mol Cancer Res       Date:  2020-07-01       Impact factor: 5.852

Review 6.  Tumor promoting role of anti-tumor macrophages in tumor microenvironment.

Authors:  Kuntal Kanti Goswami; Tithi Ghosh; Sarbari Ghosh; Madhurima Sarkar; Anamika Bose; Rathindranath Baral
Journal:  Cell Immunol       Date:  2017-04-13       Impact factor: 4.868

Review 7.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

8.  O-GlcNAc Transferase Regulates Cancer Stem-like Potential of Breast Cancer Cells.

Authors:  Neha M Akella; Giang Le Minh; Lorela Ciraku; Ayonika Mukherjee; Zachary A Bacigalupa; Dimpi Mukhopadhyay; Valerie L Sodi; Mauricio J Reginato
Journal:  Mol Cancer Res       Date:  2020-01-23       Impact factor: 5.852

9.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

10.  The lineage stability and suppressive program of regulatory T cells require protein O-GlcNAcylation.

Authors:  Bing Liu; Oscar C Salgado; Sangya Singh; Keli L Hippen; Jason C Maynard; Alma L Burlingame; Lauren E Ball; Bruce R Blazar; Michael A Farrar; Kristin A Hogquist; Hai-Bin Ruan
Journal:  Nat Commun       Date:  2019-01-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.